TRIM36 inhibits tumorigenesis through the Wnt/β-catenin pathway and promotes caspase-dependent apoptosis in hepatocellular carcinoma
Authors:
Open Access
- 6 September 2022
- journal article
- research article
- Published by Springer Nature in Cancer Cell International
- Vol. 22 (1) , 1-18
Abstract
Background: Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer and has an extremely poor prognosis. We aimed to determine the latent relationships between TRIM36 regulation of apoptosis and the Wnt/β-catenin pathway in HCC. Methods: Immunohistochemistry and western blotting were used to characterize the aberrant expression of TRIM36 in HCC and adjacent tissues. Clinical information was analyzed using Kaplan–Meier and Cox methods. RNA-seq of potential targets was conducted to detect the regulation of TRIM36. Apoptosis assays and cellular proliferation, invasion and migration were conducted in a loss- and gain-of-function manner in cultured cells to determine the biological functions of TRIM36. A rescue experiment was conducted to confirm the role of Wnt/β-catenin signaling in TRIM36 regulation. Finally, in vivo experiments were conducted using cell line-derived xenografts in nude mice to validate the central role of TRIM36 in HCC. Results: TRIM36 expression was significantly downregulated in HCC tissues compared to adjacent non-tumor tissues. TRIM36 repressed the proliferation, migration, and invasion of Huh7 and HCCLM3 cells, whereas it stimulated apoptosis. Wnt/β-catenin signaling was inhibited by TRIM36, and rescue experiments highlighted its importance in HCC proliferation, migration, and invasion. In vivo experiments further confirmed the effects of sh-TRIM36 on HCC tumorigenesis, inhibition of apoptosis, and promotion of Wnt/β-catenin signaling. Conclusion: Our study is the first to indicate that TRIM36 acts as a tumor suppressor in HCC. TRIM36 activates apoptosis and inhibits cellular proliferation, invasion, and migration via the Wnt/β-catenin pathway, which may serve as an important biomarker and promising therapeutic target for HCC.Keywords
Funding Information
- Natural Science Foundation of Xinjiang Uygur Autonomous Region (2020D01C216, 2017D01C387)
This publication has 48 references indexed in Scilit:
- Wnt Antagonist SFRP1 Functions as a Secreted Mediator of SenescenceMolecular and Cellular Biology, 2012
- Canonical Wnt signaling is antagonized by noncanonical Wnt5a in hepatocellular carcinoma cellsMolecular Cancer, 2009
- Blockade of Wnt Signaling Inhibits Angiogenesis and Tumor Growth in Hepatocellular CarcinomaCancer Research, 2009
- Trim36/Haprin plays a critical role in the arrangement of somites during Xenopus embryogenesisBiochemical and Biophysical Research Communications, 2009
- TRIM family proteins and their emerging roles in innate immunityNature Reviews Immunology, 2008
- Cholestasis is a marker for hepatocellular carcinomas displaying β‐catenin mutationsThe Journal of Pathology, 2007
- Structural basis for PRYSPRY-mediated tripartite motif (TRIM) protein functionProceedings of the National Academy of Sciences, 2007
- Balancing cell adhesion and Wnt signaling, the key role of β-cateninCurrent Opinion in Genetics & Development, 2006
- Cloning and characterisation of the RBCC728/TRIM36 zinc-binding protein from the tumor suppressor gene region at chromosome 5q22.3Gene, 2004
- Haprin, a Novel Haploid Germ Cell-specific RING Finger Protein Involved in the Acrosome ReactionJournal of Biological Chemistry, 2003